Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine as Adjunct to Outpatient Induction Onto Vivitrol
NCT03113409Phase 3Terminated
- Sponsor
- New York State Psychiatric Institute
- Start
- Jun 2017
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of buprenorphine in opioid use disorder (OUD), sponsored by New York State Psychiatric Institute. Started Jun 2017; status: terminated.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03113409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03113409.